Compositions and methods for the therapy of malignant diseases, such as
leukemia and cancer, are disclosed. The compositions comprise a WT1
polypeptide comprising an immunogenic portion of WT1, wherein said WT1
polypeptide comprises the polypeptide of SEQ ID NO:144. Such compositions
may be used, for example, for the prevention and treatment of metastatic
diseases.